099404763	099404763	CD	B-NP	O
|	|	NN	I-NP	O
OH	OH	NN	I-NP	O
|	|	NN	I-NP	O
08974898	08974898	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
4514824	4514824	CD	B-NP	O
|	|	CC	I-NP	O
10/30/2007	10/30/2007	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
supraventricular	supraventricular	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
,	,	,	O	O
hypocalcemia	hypocalcemia	NN	B-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/13/2007	3/13/2007	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/17/2007	8/17/2007	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
SPEED	SPEED	NN	B-NP	O
,	,	,	O	O
MICHEAL	MICHEAL	NN	B-NP	O
838-59-55-9	838-59-55-9	CD	I-NP	O
Hay	Hay	NNP	I-NP	O
Jome	Jome	NNP	I-NP	O
Yli	Yli	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
10/10/07	10/10/07	CD	B-NP	O
AT	AT	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MCGURN	MCGURN	NNP	B-NP	O
,	,	,	O	O
TYRONE	TYRONE	NNP	B-NP	O
K.	K.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NNP	B-NP	O
MEDICATIONS	MEDICATIONS	NNP	I-NP	O
ON	ON	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

ACETYLSALICYLIC	ACETYLSALICYLIC	NNP	B-NP	O
ACID	ACID	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CHILDREN	CHILDREN	NNP	I-NP	O
'S	'S	POS	B-NP	O
-RRB-	-RRB-	JJ	I-NP	O
81	81	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

ALBUTEROL	ALBUTEROL	NN	B-NP	B-protein
INHALER	INHALER	NN	I-NP	I-protein
HFA	HFA	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
PUFF	PUFF	NN	I-NP	I-protein
INH	INH	NN	I-NP	I-protein
Q6H	Q6H	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

CALCITRIOL	CALCITRIOL	NN	B-NP	O
1.5	1.5	CD	I-NP	O
MCG	MCG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

CALCIUM	CALCIUM	NN	B-NP	O
ACETATE	ACETATE	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
GELCAP	GELCAP	NN	I-NP	O
=	=	SYM	B-VP	O
667	667	CD	B-NP	O
MG	MG	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1334	1334	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	B-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

ERGOCALCIFEROL	ERGOCALCIFEROL	NN	B-NP	B-protein
50000	50000	CD	I-NP	I-protein
UNITS	UNITS	NNP	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QWEEK	QWEEK	NN	I-NP	I-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

FERROUS	FERROUS	DT	B-NP	O
SULFATE	SULFATE	JJ	I-NP	O
325	325	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	B-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

FUROSEMIDE	FUROSEMIDE	RB	B-NP	O
40	40	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

METOPROLOL	METOPROLOL	NNP	B-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	B-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O

SODIUM	SODIUM	NN	B-NP	B-protein
BICARBONATE	BICARBONATE	NN	I-NP	I-protein
1300	1300	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

EPOETIN	EPOETIN	NN	B-NP	B-protein
ALFA	ALFA	NN	I-NP	I-protein
10	10	CD	I-NP	I-protein
,	,	,	I-NP	O
000	000	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QWEEK	QWEEK	NNP	I-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

LISINOPRIL	LISINOPRIL	NN	B-NP	O
40	40	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

AMLODIPINE	AMLODIPINE	NN	B-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
81	81	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
4/11	4/11	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
ALBUTEROL	ALBUTEROL	NN	I-NP	B-protein
INHALER	INHALER	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
PUFF	PUFF	NNP	I-NP	I-protein
INH	INH	NNP	I-NP	O
QID	QID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Wheezing	Wheezing	NNP	I-NP	O
NORVASC	NORVASC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AMLODIPINE	AMLODIPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
4/11	4/11	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

CALCITRIOL	CALCITRIOL	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
MCG	MCG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
7/1	7/1	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PHOSLO	PHOSLO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
ACETATE	ACETATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
1	1	CD	I-NP	O
GELCAP	GELCAP	NN	I-NP	O
=	=	SYM	B-VP	O
667	667	CD	B-NP	O
MG	MG	NN	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
-RRB-	-RRB-	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
334	334	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
AC	AC	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
give	give	VB	B-VP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
Number	Number	NNP	B-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
6	6	CD	B-NP	O
CALCIUM	CALCIUM	NN	I-NP	O
CITRATE	CITRATE	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
900	900	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
give	give	VB	B-VP	O
BETWEEN	BETWEEN	NN	B-NP	O
meals	meal	NNS	I-NP	O
PROCRIT	PROCRIT	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
NON-ONCOLOGY	NON-ONCOLOGY	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
EPOETIN	EPOETIN	NN	I-NP	O
ALFA	ALFA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
NON-ONC	NON-ONC	NN	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	NN	B-NP	O
10	10	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QWEEK	QWEEK	NNP	I-NP	O
ERGOCALCIFEROL	ERGOCALCIFEROL	NNP	I-NP	O
50	50	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QWEEK	QWEEK	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
on	on	IN	B-PP	O
Wednesday	Wednesday	NNP	B-NP	O
FERROUS	FERROUS	NNP	I-NP	O
SULFATE	SULFATE	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
milk	milk	NN	I-NP	O
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	O
LASIX	LASIX	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
4/11	4/11	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
150	150	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

SODIUM	SODIUM	NN	B-NP	O
BICARBONATE	BICARBONATE	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
300	300	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Borns	Borns	NNP	I-NP	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
August	August	NNP	B-NP	O
10am	10am	CD	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NNP	B-NP	O
:	:	:	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
AMPICILLIN	AMPICILLIN	NNP	B-NP	O
,	,	,	O	O
PROCARDIA	PROCARDIA	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
renal	renal	JJ	B-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
tachycardia	tachycardia	NN	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
supraventricular	supraventricular	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
,	,	,	O	O
hypocalcemia	hypocalcemia	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
Supraventricular	Supraventricular	NNP	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
,	,	,	O	O
Stage	Stage	NN	B-NP	O
4	4	CD	I-NP	O
chronic	chronic	JJ	I-NP	O
kidney	kidney	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
NONE	NONE	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
V/Q	V/Q	NNP	I-NP	O
scan	scan	NN	I-NP	O
ECHO	ECHO	NN	I-NP	O
LENI	LENI	NN	I-NP	O
CXR	CXR	NN	I-NP	O
Adenosine	Adenosine	NN	I-NP	O
for	for	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
SVT	SVT	NN	B-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
RFA	RFA	NN	B-NP	B-protein
:	:	:	O	O
Supraventricular	Supraventricular	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
,	,	,	O	O
hypocalcemia	hypocalcemia	NN	B-NP	O
,	,	,	O	O
renal	renal	JJ	B-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

CC	CC	NN	B-NP	O
:	:	:	O	O
bilateral	bilateral	JJ	B-NP	O
foot	foot	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
sob	sob	NN	B-NP	B-protein
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
35	35	CD	B-NP	O
F	F	NN	I-NP	O
with	with	IN	B-PP	O
CKD	CKD	NN	B-NP	O
IV/V	IV/V	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
renal	renal	JJ	B-ADJP	O
:	:	:	O	O
Nickolls	Nickoll	NNS	B-NP	O
-RRB-	-RRB-	SYM	O	O
2/2	2/2	CD	B-NP	O
minimal	minimal	JJ	I-NP	O
change	change	NN	I-NP	O
dz	dz	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
USOH	USOH	NN	B-NP	O
until	until	IN	B-PP	O
6	6	CD	B-NP	O
days	day	NNS	I-NP	O
PTA	PTA	NN	I-NP	B-protein
when	when	WRB	B-ADVP	O
developed	develop	VBN	B-VP	O
bilateral	bilateral	JJ	B-NP	O
foot	foot	NN	I-NP	O
pain	pain	NN	I-NP	O
typical	typical	JJ	B-ADJP	O
of	of	IN	B-PP	O
gout	gout	NN	B-NP	O
flare	flare	NN	I-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
days	day	NNS	I-NP	O
PTA	PTA	NN	I-NP	B-protein
developed	develop	VBD	B-VP	O
SOB	SOB	NN	B-NP	B-protein
and	and	CC	I-NP	O
heart	heart	NN	I-NP	O
racing	racing	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
constant	constant	JJ	B-ADJP	O
.	.	.	O	O

Attributed	Attribute	VBN	B-NP	O
sx	sx	NN	I-NP	O
to	to	TO	B-PP	O
prednisone	prednisone	NN	B-NP	O
and	and	CC	O	O
stopped	stop	VBD	B-VP	O
prednisone	prednisone	NN	B-NP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
PTA	PTA	NN	I-NP	B-protein
.	.	.	O	O

Yet	Yet	CC	O	O
SOB	SOB	NN	B-NP	B-protein
and	and	CC	I-NP	O
sensation	sensation	NN	I-NP	O
of	of	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
heart	heart	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
continued	continue	VBN	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
never	never	RB	I-VP	O
had	have	VBN	I-VP	O
the	the	DT	B-NP	O
sensation	sensation	NN	I-NP	O
before	before	IN	B-PP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
h/o	h/o	NN	I-NP	O
tachyarrhythmia	tachyarrhythmia	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
DOA	DOA	NN	B-NP	B-protein
,	,	,	O	O
she	she	PRP	B-NP	O
came	come	VBD	B-VP	O
to	to	TO	B-VP	O
ED	ED	VB	I-VP	O
for	for	IN	B-PP	O
evalulation	evalulation	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
bilateral	bilateral	JJ	I-NP	O
gouty	gouty	NN	I-NP	O
foot	foot	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
tachycardic	tachycardic	JJ	B-ADJP	O
to	to	TO	B-PP	O
150	150	CD	B-NP	O
bpm	bpm	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
narrow	narrow	JJ	B-NP	O
complex	complex	NN	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SVT/likely	SVT/likely	NNP	I-NP	O
AVNRT	AVNRT	NNP	I-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
.	.	.	O	O

IN	IN	IN	B-PP	O
ED	ED	NNP	B-NP	O
:	:	:	O	O
given	give	VBN	B-VP	O
adenosine	adenosine	NN	B-NP	B-DNA
6	6	CD	B-NP	I-DNA
mg	mg	NN	I-NP	I-DNA
IV	IV	CD	B-NP	I-DNA
x	x	NN	I-NP	I-DNA
1	1	CD	I-NP	I-DNA
with	with	IN	B-PP	O
conversion	conversion	NN	B-NP	O
to	to	TO	B-PP	O
NSR	NSR	NN	B-NP	B-protein
for	for	IN	B-PP	O
less	less	JJR	B-NP	O
than	than	IN	B-PP	O
a	a	DT	B-NP	O
minutes	minute	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
then	then	RB	O	O
reversion	reversion	NN	B-NP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
SVT	SVT	NN	B-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
responded	respond	VBD	B-VP	O
to	to	TO	B-PP	O
additional	additional	JJ	B-NP	O
adenosine	adenosine	NN	I-NP	O
12	12	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
x	x	NN	I-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
reverted	revert	VBD	B-VP	O
to	to	TO	B-PP	O
SR	SR	NN	B-NP	B-protein
for	for	IN	B-PP	O
the	the	DT	B-NP	O
remainder	remainder	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

PMH	PMH	NN	B-NP	O
:	:	:	O	O
CKD	CKD	NN	B-NP	O
IV/V	IV/V	NN	I-NP	O
2/2	2/2	CD	I-NP	O
minimal	minimal	JJ	I-NP	O
change	change	NN	I-NP	O
dz	dz	NN	I-NP	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	B-protein
UE	UE	NN	I-NP	I-protein
AVF	AVF	NN	I-NP	I-protein
in	in	IN	B-PP	O
prep	prep	NN	B-NP	O
for	for	IN	B-PP	O
likely	likely	JJ	B-NP	O
future	future	JJ	I-NP	O
HD	HD	NN	I-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	O
,	,	,	O	O
sickle	sickle	NN	B-NP	O
cell	cell	NN	I-NP	O
trait	trait	NN	I-NP	O
,	,	,	O	O
anemia	anemia	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
h/o	h/o	NN	B-NP	B-protein
PE	PE	NN	I-NP	I-protein
s/p	s/p	NN	I-NP	I-protein
coumadin	coumadin	NN	I-NP	I-protein
,	,	,	O	O
morbid	morbid	NN	B-NP	O
obesity	obesity	NN	I-NP	O
ALLERGIES	ALLERGIES	NN	I-NP	O
:	:	:	O	O
PCN	PCN	NN	B-NP	B-protein
,	,	,	O	O
ampicillin	ampicillin	NN	B-NP	B-protein
-	-	HYPH	O	O
>	>	SYM	B-NP	O
hives	hive	NNS	I-NP	O
.	.	.	O	O

Procardia	Procardia	SYM	O	O
-	-	HYPH	O	O
>	>	SYM	B-NP	O
h/a	h/a	NN	I-NP	O
.	.	.	O	O

ADMIT	ADMIT	NN	B-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
Afeb	Afeb	NN	B-NP	O
,	,	,	O	O
hr	hr	NN	B-NP	B-protein
80	80	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	O
post	post	NN	I-NP	O
conversion	conversion	NN	I-NP	O
w	w	NN	I-NP	O
adenosine	adenosine	NN	I-NP	O
-RRB-	-RRB-	SYM	B-VP	O
BP	BP	NN	B-NP	O
118/80	118/80	CD	I-NP	O
.	.	.	O	O

100	100	CD	B-NP	O
%	%	NN	I-NP	O
2l	2l	NN	I-NP	O
NC	NC	NN	I-NP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
+8	+8	CD	I-NP	I-protein
cm	cm	NN	I-NP	O
.	.	.	O	O

lungs	lung	NNS	B-NP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

+	+	SYM	O	O
transmitted	transmit	VBN	B-NP	O
bruit	bruit	NN	I-NP	O
from	from	IN	B-PP	O
LUE	LUE	NN	B-NP	B-protein
AVF	AVF	NN	I-NP	I-protein
heard	hear	VBN	B-VP	O
throughout	throughout	IN	B-PP	O
precordium	precordium	NN	B-NP	O
.	.	.	O	O

LUE	LUE	NN	B-NP	B-protein
AVF	AVF	NN	I-NP	I-protein
with	with	IN	B-PP	O
strong	strong	JJ	B-NP	O
bruit	bruit	NN	I-NP	O
and	and	CC	I-NP	O
thrill	thrill	NN	I-NP	O
.	.	.	O	O

abd	abd	NN	B-NP	O
benign	benign	JJ	B-ADJP	O
.	.	.	O	O

Tr	Tr	NN	B-NP	O
le	le	NN	I-NP	O
edema	edema	NN	I-NP	O
at	at	IN	B-PP	O
ankles	ankle	NNS	B-NP	O
.	.	.	O	O
.	.	.	O	O

NOTABLE	NOTABLE	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
LABS	LABS	NNP	I-NP	O
:	:	:	O	O
BUN	BUN	NN	B-NP	B-DNA
80	80	CD	I-NP	I-DNA
,	,	,	O	O
Cr	Cr	NNP	B-NP	O
11.0	11.0	CD	I-NP	O
-LRB-	-LRB-	HYPH	B-VP	O
up	up	RB	B-ADVP	O
from	from	IN	B-PP	O
8	8	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
INR	INR	NNP	I-NP	O
1.2	1.2	CD	I-NP	O
WBC	WBC	NNP	I-NP	O
12.7	12.7	CD	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
N77	N77	NN	I-NP	B-protein
,	,	,	O	O
L17	L17	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
HCT	HCT	NN	B-NP	B-cell_line
26.6	26.6	CD	I-NP	I-cell_line
-LRB-	-LRB-	:	O	O
bl	bl	NN	B-NP	O
25-28	25-28	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
plt	plt	NN	B-NP	O
244	244	CD	I-NP	O
cardiac	cardiac	NN	I-NP	O
:	:	:	O	O
troponin	troponin	NN	B-NP	O
<	<	SYM	O	O
assay	assay	NN	B-NP	O
,	,	,	O	O
CK-MB	CK-MB	NN	B-NP	B-protein
2.3	2.3	CD	I-NP	I-protein
,	,	,	O	O
CK335	CK335	NN	B-NP	O
.	.	.	O	O

Calcium	Calcium	NN	B-NP	O
6.0	6.0	CD	I-NP	O
,	,	,	O	O
iCa	iCa	NN	B-NP	B-protein
0.79	0.79	CD	I-NP	I-protein
,	,	,	O	O
Mg	Mg	NNP	B-NP	O
1.6	1.6	CD	I-NP	O
.	.	.	O	O

phos	pho	NNS	B-NP	O
5.4	5.4	CD	B-NP	O
.	.	.	O	O

PTH	PTH	NN	B-NP	B-protein
914	914	CD	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
up	up	RB	B-ADVP	O
from	from	IN	B-PP	O
861	861	CD	B-NP	O
in	in	IN	B-PP	O
10/24	10/24	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

STUDIES	STUDIES	NNS	B-NP	O
:	:	:	O	O
echo	echo	NN	B-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
rv	rv	NN	I-NP	O
strain	strain	NN	I-NP	O
.	.	.	O	O

EF	EF	NN	B-NP	O
40	40	CD	I-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

+	+	SYM	O	O
diastolic	diastolic	JJ	B-NP	O
dysfxn	dysfxn	NN	I-NP	O
.	.	.	O	O

LV	LV	NN	B-NP	O
d.	d.	NN	I-NP	O
6.30	6.30	CD	I-NP	O
cm	cm	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
mild-mod	mild-mod	JJ	I-NP	O
enlarge	enlarge	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
RAE	RAE	NN	I-NP	O
,	,	,	O	O
LAE	LAE	NN	B-NP	B-protein
,	,	,	O	O
RV	RV	NN	B-NP	O
enlargement.no	enlargement.no	NN	I-NP	O
pericardial	pericardial	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

Echo	Echo	NNP	B-NP	O
is	be	VBZ	B-VP	O
significantly	significantly	RB	I-VP	O
changed	change	VBN	I-VP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-NP	O
11/21	11/21	CD	I-NP	O
when	when	WRB	B-ADVP	O
EF	EF	NN	B-NP	B-protein
was	be	VBD	B-VP	O
55-60	55-60	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
LVH	LVH	NN	I-NP	B-protein
.	.	.	O	O

cxr	cxr	NN	B-NP	O
:	:	:	O	O
cardiomegaly	cardiomegaly	RB	B-NP	O
ekg	ekg	NN	I-NP	O
10/22	10/22	CD	I-NP	O
QTC	QTC	NN	I-NP	O
=	=	SYM	B-VP	O
.504	.504	CD	B-NP	O
V/Q	V/Q	NN	I-NP	O
scan	scan	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
perfusion	perfusion	NN	I-NP	O
defect	defect	NN	I-NP	O
.	.	.	O	O

low	low	JJ	B-NP	O
probability	probability	NN	I-NP	O
.	.	.	O	O

35F	35F	NN	B-NP	O
with	with	IN	B-PP	O
h/o	h/o	NN	B-NP	O
CKD	CKD	NN	I-NP	O
IV/V	IV/V	NN	I-NP	O
2/2	2/2	CD	I-NP	O
minimal	minimal	JJ	I-NP	O
change	change	NN	I-NP	O
dz	dz	NN	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
6	6	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
DOE	DOE	NN	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
racing	race	VBG	B-VP	O
shortly	shortly	RB	B-ADVP	O
after	after	IN	B-PP	O
starting	start	VBG	B-VP	O
prednisone	prednisone	NN	B-NP	O
for	for	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
foot	foot	NN	I-NP	O
pain	pain	NN	I-NP	O
2/2	2/2	CD	I-NP	O
gout	gout	NN	I-NP	O
.	.	.	O	O

Found	Found	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
SVT	SVT	NN	B-NP	O
with	with	IN	B-PP	O
rate	rate	NN	B-NP	O
to	to	TO	B-PP	O
150	150	CD	B-NP	O
bpm	bpm	NN	I-NP	O
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
high	high	JJ	B-NP	O
suspicion	suspicion	NN	I-NP	O
of	of	IN	B-PP	O
PE	PE	NN	B-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
h/o	h/o	NN	B-NP	O
PE	PE	NN	I-NP	O
,	,	,	O	O
evolution	evolution	NN	B-NP	O
of	of	IN	B-PP	O
pleuritic	pleuritic	JJ	B-NP	B-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
SVT	SVT	NN	B-NP	B-protein
.	.	.	O	O

LENI	LENI	NNP	B-NP	O
's	's	POS	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
empirically	empirically	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	B-protein
IV	IV	CD	I-NP	I-protein
.	.	.	O	O

Yet	Yet	RB	B-ADVP	O
on	on	IN	B-PP	O
HD2	HD2	NN	B-NP	B-protein
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
V/Q	V/Q	NN	I-NP	O
scan	scan	NN	I-NP	O
with	with	IN	B-PP	O
NO	NO	NN	B-NP	O
perfusion	perfusion	NN	I-NP	O
defect	defect	NN	I-NP	O
and	and	CC	I-NP	O
heparin	heparin	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
precipitating	precipitate	VBG	I-NP	O
event	event	NN	I-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
SVT	SVT	NN	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
determined	determine	VBN	I-VP	O
.	.	.	O	O

No	No	DT	B-NP	O
PE	PE	NN	I-NP	O
or	or	CC	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
ischemic	ischemic	JJ	B-NP	O
event	event	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
metabolic	metabolic	JJ	I-NP	O
derangements	derangement	NNS	I-NP	O
,	,	,	O	O
especially	especially	RB	B-NP	O
hyocalcemia	hyocalcemia	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Ca	Ca	NNP	I-NP	O
6.0	6.0	CD	I-NP	O
,	,	,	O	O
iCa	iCa	NN	B-NP	B-protein
0.79	0.79	CD	I-NP	I-protein
,	,	,	O	O
Mg	Mg	NNP	B-NP	O
.	.	.	O	O

1.6	1.6	CD	O	O
-RRB-	-RRB-	HYPH	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
evidence	evidence	NN	B-NP	O
worsening	worsen	VBG	B-VP	O
structural	structural	JJ	B-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
evolving	evolve	VBG	B-VP	O
cardiomyopathy	cardiomyopathy	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
SVT	SVT	NN	I-NP	O
resolved	resolve	VBN	B-VP	O
after	after	IN	B-PP	O
adenosine	adenosine	NN	B-NP	B-DNA
12	12	CD	I-NP	I-DNA
mg	mg	NN	I-NP	I-DNA
IV	IV	CD	B-NP	I-DNA
x	x	NN	I-NP	I-DNA
1	1	CD	I-NP	I-DNA
and	and	CC	O	O
she	she	PRP	B-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
SR	SR	NN	B-NP	B-protein
during	during	IN	B-PP	O
the	the	DT	B-NP	O
rest	rest	NN	I-NP	O
of	of	IN	B-PP	O
hospital	hospital	NN	B-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

ECHO	ECHO	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
EF	EF	NN	B-NP	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
diastolic	diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
and	and	CC	I-NP	O
LVH	LVH	NN	I-NP	B-protein
likely	likely	RB	B-ADJP	O
2/2	2/2	CD	B-NP	O
longstanding	longstanding	JJ	I-NP	O
HTN	HTN	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
change	change	NN	I-NP	O
from	from	IN	B-PP	O
ECHO	ECHO	NN	B-NP	B-protein
in	in	IN	B-PP	O
2002	2002	CD	B-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
nl	nl	NN	B-NP	O
EF	EF	NN	I-NP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
e/o	e/o	RB	I-NP	O
diastolic	diastolic	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
ventricular	ventricular	JJ	I-NP	O
enlargement	enlargement	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
cause	cause	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
new	new	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
is	be	VBZ	B-VP	O
possibly	possibly	RB	B-ADVP	O
HTN	HTN	NN	B-NP	B-protein
and	and	CC	I-NP	O
concern	concern	NN	I-NP	O
raised	raise	VBN	B-VP	O
for	for	IN	B-PP	O
high-output	high-output	JJ	B-NP	O
state	state	NN	I-NP	O
due	due	JJ	I-NP	O
increase	increase	NN	I-NP	O
flow	flow	NN	I-NP	O
thru	thru	NN	I-NP	O
AV	AV	NN	I-NP	O
fistula	fistula	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
discussed	discuss	VBD	B-VP	O
the	the	DT	B-NP	O
case	case	NN	I-NP	O
briefly	briefly	RB	B-ADVP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
vascular	vascular	JJ	I-NP	O
surg	surg	NN	I-NP	O
service	service	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
definitive	definitive	JJ	I-NP	O
test	test	NN	I-NP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
if	if	IN	B-SBAR	O
flow	flow	NN	B-NP	O
throught	throught	VBD	B-VP	O
the	the	DT	B-NP	O
aVF	aVF	NN	I-NP	O
is	be	VBZ	B-VP	O
too	too	RB	B-ADJP	O
great	great	JJ	I-ADJP	O
.	.	.	O	O

This	This	DT	B-NP	O
may	may	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
discussed	discuss	VBN	I-VP	O
between	between	IN	B-PP	O
her	her	PRP	B-NP	O
primary	primary	JJ	I-NP	O
renal	renal	JJ	I-NP	O
doctors	doctor	NNS	I-NP	O
and	and	CC	O	O
vascular	vascular	JJ	B-ADJP	O
.	.	.	O	O
.	.	.	O	O

HYPOCALCEMIA	HYPOCALCEMIA	NN	B-NP	O
:	:	:	O	O
VitD	VitD	NN	B-NP	O
level	level	NN	I-NP	O
pending	pending	NN	I-NP	O
,	,	,	O	O
PTH	PTH	NN	B-NP	O
dramatically	dramatically	RB	B-ADJP	O
elevated	elevated	JJ	I-ADJP	O
at	at	IN	B-PP	O
914	914	CD	B-NP	O
.	.	.	O	O

Noted	Note	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
elevated	elevate	VBN	I-VP	O
QTc	QTc	NN	B-NP	O
of	of	IN	B-PP	O
QTC	QTC	NN	B-NP	B-protein
504	504	CD	I-NP	I-protein
msec	msec	NN	I-NP	I-protein
in	in	IN	B-PP	O
setting	set	VBG	B-VP	O
hypocalcemia	hypocalcemia	NN	B-NP	O
.	.	.	O	O

Calcitriol	Calcitriol	NN	B-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
and	and	CC	O	O
calcium	calcium	NN	B-NP	O
citrate	citrate	NN	I-NP	O
was	be	VBD	B-VP	O
initiated	initiate	VBN	I-VP	O
.	.	.	O	O

Calcium	Calcium	NN	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
repleted	replete	VBN	I-VP	O
with	with	IN	B-PP	O
calcium	calcium	NN	B-NP	O
gluconate	gluconate	NN	I-NP	O
boluses	bolus	NNS	I-NP	O
and	and	CC	O	O
magnesium	magnesium	NN	B-NP	O
supplementation	supplementation	NN	I-NP	O
.	.	.	O	O

Ionized	Ionize	VBN	B-NP	O
calcium	calcium	NN	I-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
Calcium	Calcium	NN	B-NP	O
citrate	citrate	NN	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
calcitriol	calcitriol	NN	B-NP	O
2mcg	2mcg	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
prior	prior	JJ	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
ergocalciferol	ergocalciferol	NN	B-NP	O
.	.	.	O	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
:	:	:	O	O
FULL	FULL	NN	B-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
You	You	PRP	B-NP	O
were	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
after	after	IN	B-PP	O
experiencing	experience	VBG	B-VP	O
a	a	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
heart	heart	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
that	that	WDT	B-NP	O
normalized	normalize	VBD	B-VP	O
after	after	IN	B-PP	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
medicine	medicine	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
clear	clear	JJ	I-NP	O
explanation	explanation	NN	I-NP	O
for	for	IN	B-PP	O
why	why	WRB	B-ADVP	O
you	you	PRP	B-NP	O
went	go	VBD	B-VP	O
into	into	IN	B-PP	O
this	this	DT	B-NP	O
abnormal	abnormal	JJ	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
are	be	VBP	B-VP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
possibilities	possibility	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
include	include	VBP	B-VP	O
disturbances	disturbance	NNS	B-NP	O
in	in	IN	B-PP	O
your	your	PRP$	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
very	very	RB	B-NP	O
low	low	JJ	I-NP	O
calcium	calcium	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-ADJP	O
low	low	JJ	I-ADJP	O
as	as	IN	B-PP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
your	your	PRP$	B-NP	O
heart	heart	NN	I-NP	O
from	from	IN	B-PP	O
high	high	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	O	O
fluid	fluid	NN	B-NP	O
retention	retention	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
clot	clot	NN	I-NP	O
to	to	TO	B-PP	O
your	your	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
or	or	CC	O	O
in	in	IN	B-PP	O
your	your	PRP$	B-NP	O
legs	leg	NNS	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	O
were	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
calcium	calcium	NN	B-NP	O
supplements	supplement	NNS	I-NP	O
-LRB-	-LRB-	VBP	B-VP	O
calcium	calcium	NN	B-NP	B-protein
citrate	citrate	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
calcitriol	calcitriol	NN	B-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
.	.	.	O	O

Metoprolol	Metoprolol	NN	B-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-VP	O
treat	treat	VB	I-VP	O
your	your	PRP$	B-NP	O
high	high	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O
.	.	.	O	O

KEY	KEY	NNP	B-NP	O
MEDICINE	MEDICINE	NNP	I-NP	O
CHANGES	CHANGES	NNPS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Increase	Increase	NN	B-NP	O
metoprolol	metoprolol	NN	I-NP	O
dose	dose	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Increase	Increase	NN	B-NP	O
calcitriol	calcitriol	NN	I-NP	O
dose	dose	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Start	Start	NN	B-NP	O
calcium	calcium	NN	I-NP	O
citrate	citrate	NN	I-NP	O
:	:	:	O	O
takes	take	VBZ	B-VP	O
this	this	DT	B-NP	O
medicine	medicine	NN	I-NP	O
BETWEEN	BETWEEN	NN	I-NP	O
meals	meal	NNS	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
it	it	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
less	less	RBR	B-ADJP	O
effective	effective	JJ	I-ADJP	O
if	if	IN	B-SBAR	O
taken	take	VBN	B-VP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
important	important	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
you	you	PRP	B-NP	O
take	take	VBP	B-VP	O
all	all	DT	B-NP	O
prescribed	prescribe	VBN	I-NP	O
medicines	medicine	NNS	I-NP	O
to	to	TO	B-VP	O
keep	keep	VB	I-VP	O
your	your	PRP$	B-NP	O
heart	heart	NN	I-NP	O
healthy	healthy	JJ	B-ADJP	O
and	and	CC	O	O
to	to	TO	B-VP	O
make	make	VB	I-VP	O
sure	sure	JJ	B-ADJP	O
your	your	PRP$	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
and	and	CC	O	O
calcium	calcium	NN	B-NP	O
stay	stay	NN	I-NP	O
in	in	IN	B-PP	O
acceptable	acceptable	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
problems	problem	NNS	B-NP	O
filling	fill	VBG	B-VP	O
your	your	PRP$	B-NP	O
medicines	medicine	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
notifiy	notifiy	RB	B-ADVP	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
or	or	CC	I-NP	O
renal	renal	JJ	I-NP	O
doctors	doctor	NNS	I-NP	O
.	.	.	O	O
.	.	.	O	O

Contact	Contact	VB	B-VP	O
a	a	DT	B-NP	O
physician	physician	NN	I-NP	O
or	or	CC	O	O
return	return	VB	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
develop	develop	VBP	B-VP	O
recurrent	recurrent	JJ	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
sensation	sensation	NN	B-NP	O
of	of	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
heart	heart	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
that	that	WDT	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
go	go	VB	I-VP	O
away	away	RB	B-ADVP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
minutes	minute	NNS	I-NP	O
or	or	CC	O	O
comes	come	VBZ	B-VP	O
on	on	RP	B-PRT	O
with	with	IN	B-PP	O
breathing	breathing	NN	B-NP	O
problems	problem	NNS	I-NP	O
or	or	CC	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Check	Check	VB	B-VP	O
metabolic	metabolic	JJ	B-NP	O
panel	panel	NN	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
calcium	calcium	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

F/u	F/u	NN	B-NP	O
on	on	IN	B-PP	O
vitamin	vitamin	NN	B-NP	B-protein
D	D	NN	I-NP	I-protein
level	level	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
pending	pende	VBG	B-VP	O
at	at	IN	B-PP	O
d/c	d/c	NN	B-NP	B-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
3	3	CD	I-NP	I-DNA
.	.	.	O	O

Check	Check	NN	B-NP	B-protein
BP	BP	NN	I-NP	I-protein
on	on	IN	B-PP	O
elevated	elevate	VBN	B-NP	O
dose	dose	NN	I-NP	O
metoprolol	metoprolol	NN	I-NP	O
ER	ER	NN	I-NP	B-protein
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
KLINGBEIL	KLINGBEIL	NNP	B-NP	O
,	,	,	O	O
ALFREDO	ALFREDO	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
RG599	RG599	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/10/07	10/10/07	CD	I-NP	O
@	@	HYPH	B-NP	O
12	12	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

